Federated Hermes Inc. lifted its position in shares of Outset Medical, Inc. (NASDAQ:OM – Free Report) by 1,785.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 264,000 shares of the company’s stock after buying an additional 250,000 shares during the period. Federated Hermes Inc. owned about 0.54% of Outset Medical worth $4,858,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Bailard Inc. bought a new stake in Outset Medical during the first quarter worth about $299,000. Perpetual Ltd bought a new stake in Outset Medical during the first quarter worth about $212,000. Assetmark Inc. raised its holdings in Outset Medical by 16.3% during the first quarter. Assetmark Inc. now owns 4,733 shares of the company’s stock worth $87,000 after acquiring an additional 662 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in Outset Medical by 5.4% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 21,296 shares of the company’s stock worth $392,000 after acquiring an additional 1,099 shares in the last quarter. Finally, Jump Financial LLC bought a new stake in Outset Medical in the first quarter valued at approximately $1,406,000.
Insider Transactions at Outset Medical
In other news, General Counsel John L. Brottem sold 1,415 shares of the stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $20.00, for a total transaction of $28,300.00. Following the transaction, the general counsel now owns 58,945 shares in the company, valued at $1,178,900. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, General Counsel John L. Brottem sold 1,415 shares of the stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $20.00, for a total transaction of $28,300.00. Following the sale, the general counsel now owns 58,945 shares of the company’s stock, valued at $1,178,900. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Leslie Trigg sold 20,000 shares of the stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $21.10, for a total value of $422,000.00. Following the sale, the chief executive officer now directly owns 409,489 shares in the company, valued at approximately $8,640,217.90. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,541 shares of company stock worth $996,329. Company insiders own 4.00% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Report on Outset Medical
Outset Medical Stock Performance
NASDAQ:OM opened at $16.11 on Tuesday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 5.43 and a current ratio of 6.34. Outset Medical, Inc. has a 12-month low of $11.41 and a 12-month high of $30.55. The stock’s 50 day moving average price is $20.18 and its two-hundred day moving average price is $21.08.
About Outset Medical
Outset Medical, Inc, a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings.
Featured Articles
- Five stocks we like better than Outset Medical
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Sizzling Dividends That Are Going On Sale
- Insider Buying Explained: What Investors Need to Know
- 3 Ways To Trade, Trade Desk Stock Post Earnings
- What is a Mid Cap Stock? How to Invest
- Inflation, The Fed, and Oil Prices: Interest Rates Are Going Up
Want to see what other hedge funds are holding OM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Outset Medical, Inc. (NASDAQ:OM – Free Report).
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.
